Pfizer Shifts Focus from Acquisitions to AI Transformation
Pfizer (NYSE: PFE) has indicated that it will not pursue major acquisitions in the next couple of years, instead focusing on leveraging artificial intelligence across its operations. This strategic shift aims to enhance efficiency and growth amid patent cliffs for key drugs.
Tickers: $PFE
Topics: Artificial Intelligence (AI) Mergers & Acquisitions Pharmaceutical Industry Strategy